Total Payments
$1,994
2024 Payments
$199.88
Companies
23
Transactions
115
Medicare Patients
2,677
Medicare Billing
$176,649
Payment Breakdown by Category
Food & Beverage$1,994 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,994 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sun Pharmaceutical Industries Inc. | $376.14 | 22 | $0 (2023) |
| Oyster Point Pharma, Inc. | $301.88 | 12 | $0 (2024) |
| Allergan, Inc. | $212.52 | 15 | $0 (2021) |
| Shire North American Group Inc | $152.81 | 8 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $116.51 | 8 | $0 (2023) |
| ABBVIE INC. | $100.80 | 6 | $0 (2022) |
| Alcon Vision LLC | $91.70 | 5 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $84.38 | 6 | $0 (2021) |
| Johnson & Johnson Vision Care, Inc. | $56.68 | 3 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $54.82 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.88 | 11 | Tarsus Pharmaceuticals, Inc. ($54.82) |
| 2023 | $294.11 | 14 | Sun Pharmaceutical Industries Inc. ($207.65) |
| 2022 | $747.87 | 41 | Oyster Point Pharma, Inc. ($245.13) |
| 2021 | $243.23 | 18 | Allergan, Inc. ($121.80) |
| 2020 | $69.43 | 5 | Aerie Pharmaceuticals, Inc. ($27.33) |
| 2019 | $56.28 | 4 | Allergan Inc. ($14.78) |
| 2018 | $40.33 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($15.58) |
| 2017 | $343.29 | 19 | Shire North American Group Inc ($139.94) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $19.59 | General |
| 09/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Dry eyes | ||||||
| 05/23/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Ophthalmology | ||||||
| 04/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/12/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Ophthalmology | ||||||
| 02/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Ophthalmology | ||||||
| 11/20/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: DRY EYE | ||||||
| 10/12/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: DRY EYE | ||||||
| 05/31/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Ophthalmology | ||||||
| 05/31/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: Ophthalmology | ||||||
| 05/10/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Ophthalmology | ||||||
| 05/10/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Ophthalmology | ||||||
| 05/02/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Ophthalmology | ||||||
| 05/02/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: Ophthalmology | ||||||
| 04/20/2023 | Alcon Vision LLC | DAILIES (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Ophthalmology | ||||||
| 03/24/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Ophthalmology | ||||||
| 03/10/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Ophthalmology | ||||||
| 02/24/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Ophthalmology | ||||||
| 02/15/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: Ophthalmology | ||||||
| 01/17/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 58 | 59 | $10,395 | $6,813 |
| 2021 | 8 | 1,283 | 1,428 | $280,912 | $82,939 |
| 2020 | 9 | 1,336 | 1,487 | $303,119 | $86,896 |
Total Patients
2,677
Total Services
2,974
Medicare Billing
$176,649
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 30 | $5,115 | $3,375 | 66.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,860 | $2,383 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $1,420 | $1,056 | 74.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 511 | 524 | $149,864 | $46,228 | 30.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 196 | 291 | $55,017 | $20,793 | 37.8% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 303 | 315 | $28,665 | $5,841 | 20.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 62 | 62 | $16,120 | $3,184 | 19.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 86 | 108 | $14,904 | $3,082 | 20.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 58 | 60 | $9,120 | $1,829 | 20.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 11 | 11 | $3,916 | $1,263 | 32.3% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 56 | 57 | $3,306 | $719.32 | 21.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 504 | 517 | $157,309 | $47,975 | 30.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 191 | 292 | $59,832 | $19,765 | 33.0% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2020 | 304 | 314 | $28,574 | $6,509 | 22.8% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 64 | 66 | $17,160 | $3,382 | 19.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 91 | 113 | $15,594 | $3,363 | 21.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 30 | 30 | $10,468 | $2,769 | 26.4% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 46 | 46 | $6,992 | $1,551 | 22.2% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2020 | 92 | 95 | $5,510 | $1,023 | 18.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 14 | $1,680 | $559.88 | 33.3% |
About Dr. Eric Saunders, MD
Dr. Eric Saunders, MD is a Ophthalmology healthcare provider based in Glen Rock, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699730937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Saunders, MD has received a total of $1,994 in payments from pharmaceutical and medical device companies, with $199.88 received in 2024. These payments were reported across 115 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,994).
As a Medicare-enrolled provider, Saunders has provided services to 2,677 Medicare beneficiaries, totaling 2,974 services with total Medicare billing of $176,649. Data is available for 3 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Glen Rock, NJ
- Active Since 04/19/2006
- Last Updated 08/05/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1699730937
Products in Payments
- Cequa (Drug) $376.14
- TYRVAYA (Drug) $301.88
- XIIDRA (Drug) $221.05
- DURYSTA (Drug) $160.17
- VYZULTA (Drug) $61.23
- rhopressa (Drug) $56.92
- XDEMVY (Drug) $54.82
- Izervay (Drug) $52.83
- RESTASIS (Drug) $48.77
- DUREZOL (Drug) $48.27
- LUMIGAN (Drug) $46.30
- PROLENSA (Drug) $45.80
- VUITY (Drug) $39.12
- PROKERA (Device) $38.91
- Acuvue (Device) $37.09
- DAILIES TOTAL1 (Device) $36.35
- TEPEZZA (Biological) $34.54
- Avenova (Device) $32.43
- INVELTYS (Drug) $31.39
- MyDay Contact Lens (Device) $31.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Glen Rock
Adam Friend, Md, MD
Ophthalmology — Payments: $11,697
Ophthalmology $11,697
Kunal Merchant, M.d, M.D
Ophthalmology — Payments: $5,127
Ophthalmology $5,127
Dr. Nathaniel Kheysin, Md, MD
Ophthalmology — Payments: $218.45
Ophthalmology $218.45
Dr. Almerindo Portfolio, M.d, M.D
Ophthalmology — Payments: $210.97
Ophthalmology $210.97